Navigation Links
ContextVision Gains Asian Market Share, Signs Three New Mammography Contracts
Date:6/4/2013

Boston, MA and Stockholm, Sweden (PRWEB) June 04, 2013

A recent Frost & Sullivan report highlights the growing trend of digitalization in the Asian medical imaging market. As more companies convert from analogue to digital, ContextVision, software imaging partner for the most recognized medical imaging manufacturers worldwide, continues its expansion in Asia with three new mammography contracts.

Misconceptions about mammography, a global shortage of radiologists, and insufficient access to mammography services currently plague the imaging industry. These barriers result in an increase in undiagnosed or misdiagnosed breast cancer cases.

GOPView® Mammo, ContextVision’s image enhancement software product specifically developed for mammography provides:

  •     Optimized contrast between pectoral muscle, fat and parenchyma as well as within the parenchyma for each breast;
  •     Efficient noise suppression balanced with a strengthening of edges and fine structures;
  •     Visualization of subtle structures through the parenchyma;
  •     Customizable features for different manufacturers’ needs.

“ContextVision has been in the Asian market for more than 10 years. Our market share is steadily increasing due to high demand from Asian OEMs for our unsurpassed mammography image enhancement products,” said Anita Tollstadius, CEO of ContextVision. “These strong partner relationships and new contracts are important to ContextVision’s continued growth and success in the Asian market.”

For more information about ContextVision, please visit http://www.contextvision.com.

About ContextVision
ContextVision is a leading provider of image enhancement software to the global medical imaging industry since 1983, with the versatile GOP® technology at its core. We play a key role in helping manufacturers by offering clinicians unparalleled diagnostic image quality, ultimately providing patients with better care. ContextVision continues to offer the latest software and expertise within ultrasound, x-ray, magnetic resonance imaging, mammography, fluoroscopy and computed tomography. Our groundbreaking technology and lengthy expertise have granted us a pioneer position within 2D/3D/4D image enhancement across multiple modalities. For more information, please visit http://www.contextvision.com.

Read the full story at http://www.prweb.com/releases/2013/6/prweb10799296.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Scientists identify major source of cells defense against oxidative stress
2. Omega-3 Supplements No Help Against Repeat Heart Trouble: Review
3. Kinase test may yield big gains for drug-resistant cancers
4. Will women use microbicides to protect themselves against HIV?
5. Vitamin E in diet protects against many cancers
6. Lower-Dose Radioiodine Effective Against Thyroid Cancer
7. Study identifies possible protective blood factors against Type 2 diabetes
8. New study of NIH funding allocations suggests potential efficiency gains
9. Stem Cell Study Shows Promising Results Against Heart Failure
10. Blood pressure drugs dont protect against colorectal cancer
11. CNIO scientists successfully test the first gene therapy against aging-associated decline
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2017)... ... ... Pastor and Overseer at The House of Yahweh in Abilene, Texas, has published a new ... not. Yisrayl says with so many titles and names for the Creator, it’s hard ... a little Scripture, backed with a lot of research, the truth is undeniable. , ...
(Date:4/28/2017)... ... April 28, 2017 , ... Woolsy Corporation Limited, a ... its Nova Skin Sciences division, recently announced the launch of Allumière Antiaging Cream, ... power of an anti-aging concentrate. , Anogeissus Leiocarpa Bark Extract and ...
(Date:4/28/2017)... Tenn. (PRWEB) , ... April 28, 2017 , ... ... system, today announced an alliance with B. Braun Medical Inc. , a leader ... role in patient care with as many as 90 percent of hospital patients receiving ...
(Date:4/27/2017)... , ... April 27, 2017 , ... ... natural deodorant. On the heels of Thinksport’s award-winning sunscreen they’ve used the same ... that actually works! , Countless deodorants flood the aisles that contain harmful chemicals ...
(Date:4/27/2017)... ... April 27, 2017 , ... Goodcents Deli Fresh Subs announced ... Lincoln, Neb. area this year. , The first new location will open at ... will open at 84th and Northern Lights Drive this fall. And the third location ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... NEW YORK , April 19, 2017 /PRNewswire/ ... This report on the prostate cancer ... of the global market. Increasing prevalence of prostate ... as innovation in the development of new drugs ... hormone-refractory prostate cancer drug due to lesser side ...
(Date:4/19/2017)... April 19, 2017  Sorrento Therapeutics, Inc. (NASDAQ: ... biopharmaceutical company developing new treatments for cancer and ... of its previously announced underwritten public offering of ... public offering price of $2.00 per share, before ... expenses payable by Sorrento.  The net proceeds to ...
(Date:4/19/2017)... N.J. , April 19, 2017  Novartis ... by the National Heart, Lung, and Blood Institute ... demonstrating that 58% of patients with treatment-naïve severe ... months when treated with eltrombopag at the initiation ... . The study evaluated three sequential treatment groups, ...
Breaking Medicine Technology: